{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:31:03Z","timestamp":1782603063608,"version":"3.54.5"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,11]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>The aim of the present review is to analyze the link between autoimmune diseases and environmental factors, in particular severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (COVID-19) as it shares numerous features with the interstitial lung disease associated with connective tissue diseases positive for rare autoantibodies directed at highly specific autoantigens (i.e., MDA5 and RIG1) among the intracellular sensors of SARS-CoV-2 in the innate response against viruses.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>As shown in recent publications and in our original data, specific autoantibodies may be functionally relevant to COVID-19 infection. We evaluated sera from 35 hospitalized patients with COVID-19 to identify antinuclear antibodies and autoantibodies directed against specific antigenic targets, and we identified anti-nuclear antibodies (ANA) in 20\/35 of patients with COVID-19 (57%), in patients with need for supplemental oxygen (90% vs. 20% in ANA-negative cases; <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a0.0001). In 7\/35 COVID-19 sera, we detected anti-MJ\/NXP2 (<jats:italic toggle=\"yes\">n<\/jats:italic>\u200a=\u200a3), anti-RIG1 (<jats:italic toggle=\"yes\">n<\/jats:italic>\u200a=\u200a2), anti-Scl-70\/TOPO1 (<jats:italic toggle=\"yes\">n<\/jats:italic>\u200a=\u200a1), and anti-MDA5 (<jats:italic toggle=\"yes\">n<\/jats:italic>\u200a=\u200a1), overall associated with a significantly worse pulmonary involvement at lung computerized tomography scans. Eleven (31%) patients were positive for antibodies against the E2\/E3 subunits of mitochondrial pyruvate dehydrogenase complex.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Viral infections such as COVID-19 are associated with ANA and autoantibodies directed toward antiviral signaling antigens in particular in patients with worse pulmonary involvement.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/bor.0000000000000844","type":"journal-article","created":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T20:01:28Z","timestamp":1631304088000},"page":"514-521","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":19,"title":["Environmental triggers for connective tissue disease: the case of COVID-19 associated with dermatomyositis-specific autoantibodies"],"prefix":"10.1097","volume":"33","author":[{"given":"Maria","family":"De Santis","sequence":"first","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Humanitas Clinical and Research Center \u2013 IRCCS"},{"name":"Department of Biomedical Sciences, Humanitas University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasa","family":"Isailovic","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Humanitas Clinical and Research Center \u2013 IRCCS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Motta","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Humanitas Clinical and Research Center \u2013 IRCCS"},{"name":"Department of Biomedical Sciences, Humanitas University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Ricordi","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Humanitas University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Ceribelli","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Humanitas Clinical and Research Center \u2013 IRCCS"},{"name":"Department of Biomedical Sciences, Humanitas University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezio","family":"Lanza","sequence":"additional","affiliation":[{"name":"Department of Radiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Azzolini","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Humanitas University"},{"name":"Department of Medical Direction"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Badalamenti","sequence":"additional","affiliation":[{"name":"Department of Nephrology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Voza","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Humanitas University"},{"name":"Emergency Department, Humanitas Clinical and Research Center \u2013 IRCCS, Rozzano, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Selmi","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Humanitas Clinical and Research Center \u2013 IRCCS"},{"name":"Department of Biomedical Sciences, Humanitas University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,9,9]]},"reference":[{"key":"R1-20250526","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1749-6632.1997.tb52078.x","article-title":"Herpes viruses in multicase families with rheumatoid arthritis and systemic lupus erythematosus","volume":"5","author":"Dostal","year":"1997","journal-title":"Ann NY Acad Sci"},{"key":"R2-20250526","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1093\/rheumatology\/kex162","article-title":"Environmental factors associated with disease flare in juvenile and adult dermatomyositis","volume":"56","author":"Mamyrova","year":"2017","journal-title":"Rheumatology"},{"key":"R3-20250526","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13395-021-00266-5","article-title":"Severe acute myopathy following SARS-CoV-2 infection: a case report and review of recent literature","volume":"11","author":"Islam","year":"2021","journal-title":"Skelet Muscle"},{"key":"R4-20250526","doi-asserted-by":"crossref","first-page":"102592","DOI":"10.1016\/j.jaut.2020.102592","article-title":"The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 \u2013 a systematic review of the literature","volume":"117","author":"Novelli","year":"2021","journal-title":"J Autoimmun"},{"key":"R5-20250526","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/cts.12908","article-title":"COVID-19 and immunological dysregulation: can autoantibodies be useful?","volume":"14","author":"Pascolini","year":"2021","journal-title":"Clin Transl Sci"},{"key":"R6-20250526","doi-asserted-by":"crossref","first-page":"102597","DOI":"10.1016\/j.autrev.2020.102597","article-title":"Covid-19 and autoimmunity","volume":"19","author":"Ehrenfeld","year":"2020","journal-title":"Autoimmun Rev"},{"key":"R7-20250526","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/BOR.0000000000000776","article-title":"COVID-19 and autoimmune diseases","volume":"33","author":"Liu","year":"2021","journal-title":"Curr Opin Rheumatol"},{"key":"R8-20250526","doi-asserted-by":"crossref","first-page":"e001295","DOI":"10.1136\/rmdopen-2020-001295","article-title":"Storm, typhoon, cyclone or hurricane in patients with COVID-19? Beware of the same storm that has a different origin","volume":"6","author":"Alunno","year":"2020","journal-title":"RMD Open"},{"key":"R9-20250526","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/BOR.0000000000000822","article-title":"Is severe COVID-19 a cytokine storm syndrome: a hyperinflammatory debate","volume":"33","author":"Mehta","year":"2021","journal-title":"Curr Opin Rheumatol"},{"key":"R10-20250526","doi-asserted-by":"crossref","first-page":"102442","DOI":"10.1016\/j.jaut.2020.102442","article-title":"Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy","volume":"109","author":"Ceribelli","year":"2020","journal-title":"J Autoimmun"},{"key":"R11-20250526","article-title":"Similarities and differences between severe COVID-19 pneumonia and anti-MDA-5-positive dermatomyositis-associated rapidly progressive interstitial lung diseases: a challenge for the future","author":"Wang","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"R12-20250526","first-page":"383","article-title":"Analysis of thin-section CT in patients with coronavirus disease (COVID-19) after hospital discharge","volume":"28","author":"Wei","year":"2020","journal-title":"J Xray Sci Technol"},{"key":"R13-20250526","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature04734","article-title":"Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses","volume":"441","author":"Kato","year":"2006","journal-title":"Nature"},{"key":"R14-20250526","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s00296-021-04819-1","article-title":"Understanding and managing anti-MDA 5 dermatomyositis, including potential COVID-19 mimicry","volume":"41","author":"Mehta","year":"2021","journal-title":"Rheumatol Int"},{"key":"R15-20250526","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1136\/annrheumdis-2020-217522","article-title":"Antibodies against immunogenic epitopes with high sequence identity to SARS-CoV-2 in patients with autoimmune dermatomyositis","volume":"79","author":"Megremis","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"R16-20250526","doi-asserted-by":"crossref","first-page":"A330","DOI":"10.1016\/j.autrev.2009.11.006","article-title":"The geoepidemiology of autoimmune muscle disease","volume":"9","author":"Prieto","year":"2010","journal-title":"Autoimmun Rev"},{"key":"R17-20250526","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/rheumatology\/ken038","article-title":"Assessment of an infectious disease history preceding juvenile dermatomyositis symptom onset","volume":"47","author":"Manlhiot","year":"2008","journal-title":"Rheumatology"},{"key":"R18-20250526","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/art.21068","article-title":"History of infection before the onset of juvenile dermatomyositis: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Research Registry","volume":"53","author":"Pachman","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R19-20250526","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12016-015-8510-y","article-title":"A comprehensive overview on myositis-specific antibodies: new and old biomarkers in idiopathic inflammatory myopathy","volume":"52","author":"Satoh","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"R20-20250526","first-page":"891","article-title":"Prevalence and clinical significance of anti-MDA5 antibodies in European patients with polymyositis\/dermatomyositis","volume":"32","author":"Ceribelli","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"R21-20250526","doi-asserted-by":"crossref","first-page":"R97","DOI":"10.1186\/ar3822","article-title":"Anti-MJ\/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis\/dermatomyositis","volume":"14","author":"Ceribelli","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"R22-20250526","doi-asserted-by":"crossref","first-page":"R111","DOI":"10.1186\/ar2000","article-title":"Autoantibodies against the replication protein A complex in systemic lupus erythematosus and other autoimmune diseases","volume":"8","author":"Yamasaki","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"R23-20250526","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1001\/archneurol.2011.1728","article-title":"Myopathy associated with antibodies to signal recognition particle: disease progression and neurological outcome","volume":"69","author":"Suzuki","year":"2012","journal-title":"Arch Neurol"},{"key":"R24-20250526","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1111\/cts.12805","article-title":"Clinical and autoimmune characteristics of severe and critical cases of COVID-19","volume":"13","author":"Zhou","year":"2020","journal-title":"Clin Transl Sci"},{"key":"R25-20250526","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1136\/annrheumdis-2020-218009","article-title":"Autoantibodies related to systemic autoimmune rheumatic diseases in severely ill patients with COVID-19","volume":"79","author":"Vlachoyiannopoulos","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"R26-20250526","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/bjd.14882","article-title":"Antimelanoma differentiation-associated protein 5 antibody level is a novel tool for monitoring disease activity in rapidly progressive interstitial lung disease with dermatomyositis","volume":"176","author":"Matsushita","year":"2017","journal-title":"Br J Dermatol"},{"key":"R27-20250526","doi-asserted-by":"crossref","first-page":"e813","DOI":"10.1212\/NXI.0000000000000813","article-title":"CNS inflammatory vasculopathy with antimyelin oligodendrocyte glycoprotein antibodies in COVID-19","volume":"7","author":"Pinto","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"R28-20250526","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s00415-020-10108-x","article-title":"Immune-mediated neurological syndromes in SARS-CoV-2-infected patients","volume":"268","author":"Guilmot","year":"2021","journal-title":"J Neurol"},{"key":"R29-20250526","doi-asserted-by":"crossref","first-page":"e02415","DOI":"10.1128\/JVI.02415-20","article-title":"SARS-CoV-2 triggers an MDA-5-dependent interferon response which is unable to control replication in lung epithelial cells","volume":"95","author":"Rebendenne","year":"2021","journal-title":"J Virol"},{"key":"R30-20250526","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/s41591-020-0901-9","article-title":"Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19","volume":"26","author":"Liao","year":"2020","journal-title":"Nat Med"},{"key":"R31-20250526","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.chom.2020.04.017","article-title":"Heightened innate immune responses in the respiratory tract of COVID-19 patients","volume":"27","author":"Zhou","year":"2020","journal-title":"Cell Host Microbe"},{"key":"R32-20250526","doi-asserted-by":"crossref","first-page":"108628","DOI":"10.1016\/j.celrep.2020.108628","article-title":"MDA5 governs the innate immune response to SARS-CoV-2 in lung epithelial cells","volume":"34","author":"Yin","year":"2021","journal-title":"Cell Rep"},{"key":"R33-20250526","doi-asserted-by":"crossref","first-page":"aad7993","DOI":"10.1126\/science.aad7993","article-title":"Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation","volume":"352","author":"Rialdi","year":"2016","journal-title":"Science"},{"key":"R34-20250526","doi-asserted-by":"crossref","first-page":"20611","DOI":"10.1074\/jbc.M201440200","article-title":"The newly identified human nuclear protein NXP-2 possesses three distinct domains, the nuclear matrix-binding, RNA-binding, and coiled-coil domains","volume":"277","author":"Kimura","year":"2002","journal-title":"J Biol Chem"},{"key":"R35-20250526","first-page":"hcab043","article-title":"COVID-19 vaccine-related myositis","author":"Theodorou","year":"2021","journal-title":"QJM"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000844","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T22:00:30Z","timestamp":1748296830000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,9]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000844","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,9]]}}}